Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT00362986
First received: August 10, 2006
Last updated: August 12, 2016
Last verified: August 2016